首页 | 本学科首页   官方微博 | 高级检索  
     


Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis
Authors:Chappuis  Maëlle  Rousseau   Chloé  Bajeux  Emma  Wiertlewski  Sandrine  Laplaud  David  Le Page  Emmanuelle  Michel  Laure  Edan  Gilles  Kerbrat  Anne
Affiliation:1.Department of Neurology, University Hospital, Rennes, France
;2.Research Management Department, University Hospital, Rennes, France
;3.Department of Epidemiology and Public Health, University Hospital, Rennes, France
;4.Department of Neurology, University Hospital, Nantes, France
;5.CIC-P 1414 Inserm, University Hospital, Rennes, France
;
Abstract:Journal of Neurology - There has been scant research on the consequences of discontinuing second-line disease-modifying treatment (DMT) in middle-aged patients with multiple sclerosis (MS). The...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号